Quinidine gluc ER 324 MG tab 100S
Ended Awarded
- Contract number
- SPE2DB25FTSZ9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,499
Award facts
- Contract value 100% obligated
- $10,498.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $10,498.61 and awarded on July 29, 2025, is for the supply of Quinidine Glucuronate Extended Release 324 mg tablets (100-count bottles) to support federal medical procurement needs. The Defense Logistics Agency (DLA), under its Medical Supply Chain operations, awarded this firm fixed-price contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract represents a non-competitive set-aside award and carries an ultimate completion date of July 30, 2025, with performance at the vendor's corporate office location in Conshohocken, PA.
This delivery order is executed under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The IDC enables the company to fulfill a comprehensive range of pharmaceutical products and medical supplies supporting military healthcare programs worldwide, including specialty medications, generic drugs, and critical medical commodities across multiple therapeutic domains. AmerisourceBergen Drug Corp's demonstrated capability to meet federal procurement requirements through open competition, combined with its extensive portfolio of federal medical product deliveries, positions it as a key vendor within DLA's pharmaceutical supply chain serving the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FTSZ9?
SPE2DB25FTSZ9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 29, 2025.
How much is contract SPE2DB25FTSZ9 worth?
The government has obligated $10,499 on SPE2DB25FTSZ9.
Is contract SPE2DB25FTSZ9 an order under another contract?
Yes. SPE2DB25FTSZ9 is a delivery order under SPE2DB22D1103, an indefinite delivery contract.
Was contract SPE2DB25FTSZ9 competed?
The extent of competition for SPE2DB25FTSZ9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award